U.S. In Vitro Fertilization (IVF) Services Market
The In Vitro Fertilization (IVF) market size in U.S. was valued at $4,905.46 million in 2020, and is expected to reach $5,563.06 million by 2027, registering a CAGR of 6.8% from 2019 to 2027. The IVF market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of late pregnancies, surge in IVF success rate, and rise in disposable income in the region.
IVF is one of the widely used treatments, which assisted couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, technological advancements in IVF treatment, growth in rate of infertility and practices of embryo banking cycles and growth in disposable income in U.S drive the growth of the In Vitro Fertilization market. Moreover, rise in popularity of IVF in the U.S, growth in rate of infertility and practices of embryo banking cycles, technological advancements in IVF treatment, and delayed pregnancy trends are expected to make way for the expansion of the U.S. IVF market in the future.
Due to this COVID-19 pandemic lockdowns throughout the U.S have fairly limited some of the sub-markets of IVF. Many hospitals maximize wellbeing of patients, staff, and society at large. There is a confusing picture of the effect of COVID-19 on fertility treatments, with the advice and guidance coming from several different resources such as ASRM (American Society of Reproductive Medicine) 2020. Some women have postponed their IVF consultations, whereas others have delayed their dates of embryo transfer until the pandemic situation ends and life comes back to normal. mnbvjjhh
According to a research article titled “Suspension of fertility treatments during COVID-19 has mental health impacts”, published in September 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced their recommendations to immediately and indefinitely suspend all in-person fertility treatments in the United States and Canada due to COVID-19 from March 17, 2020. As a result, 86% of couples in treatment reported that treatment suspensions had a negative impact on their mental health, and 52% reported clinically significant depression symptoms. Also, the recommendations included suspending initiation of new treatments and an alternative freeze-all protocol in cases where couples have already undergone human chorionic gonadotrophin triggering and consideration of cryopreservation of gametes for cases of urgent fertility preservation. Thus, the COVID-19 pandemic is expected to have a tremendous impact on the growth of the studied market.
U.S presents productive opportunities for players operating in the IVF market, owing to its high population base, growth in knowledge about IVF treatment, rise in popularity of IVF in the U.S, growth in rate of infertility and practices of embryo banking cycles, technological advancements in IVF treatment, and delayed pregnancy trends. According to the Centers for Disease Control and Prevention (CDC), the rate of fertilization in the age group of 35 to 39 years through IVF procedure is considerably high. In older women (more than 40 years age group), eggs produced by reproductive system are not fully formed for the process of fertilization, which result in risk of genetic disorders in the egg. Moreover, aging individuals experience a decline in production of healthy eggs and increased chance of miscarriage. Thus, increase in trend of delayed pregnancy in women is anticipated to drive growth of the IVF market in North America.
However, problems associated with IVF treatment such as multiple pregnancies and birth defects limit, restrictions on three-parent IVF treatments, scattered reimbursements, and high cost of IVF treatments in the U.S hinders growth of the market. In addition, the U.S. FDA has banned three-parent IVF treatments on grounds of safety toward embryos and mothers. This factor affects growth of the In Vitro Fertilization market in the U.S. Furthermore, rise in same sex marriages pose a moderate impact on growth of the In Vitro Fertilization market. The demand for IVF procedures is on the rise across same sex couples, owing to high success rate. Thus, rise in same sex marriages is expected to boost the demand for IVF services.
Rise in focus of key players in the U.S. is primarily set to contribute to growth of the In Vitro Fertilization market. The healthcare expenditure per capita is growing steadily in the region, which is expected to boost the growth. Increase in incidences of gynecological conditions, coupled with delayed pregnancy in women fuel the market. Moreover, increase in number of technological advancements of IVF procedures, along with focus and investments by major players is expected to provide several opportunities for the market growth in future. Hence, a rapid growth of the IVF services market is expected during the forecast period in the U.S.
U.S. IVF Services Market Segmentation
The U.S IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
Cycle Type segment review
By cycle type, the fresh cycle (non-donor) segment was the major revenue contributor in 2019, and accounted for 170.19 thousand cycles. This segment is expected to dominate the market during the forecast period.
By Cycle Type
Fresh Cycle (non-donor) segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.
End User segment review
By end user, fertility clinics and clinical research institute play a crucial role in providing IVF treatments to couples seeking assistance for infertility treatments. The fertility clinics segment is expected to be the largest revenue-generating segment from 2019 to 2027.
By End User
Fertility Clinics Segment is projected as one of the most lucrative segment.
Major companies, hospitals, surgical centers, fertility centers, and clinical research institutes are profiled in this report. The major key players included in this report are Boston IVF, Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.
Key Benefits For Stakeholders
- The U.S. IVF Services market share and analysis is based on a comprehensive analysis of key developments in the IVF services.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the U.S. market.
- The study provides an in-depth analysis of the In Vitro Fertilization market trends to elucidate the imminent investment pockets.
- The IVF market in U.S. trends are studied from 2019 to 2027.
- Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
- The quantitative analysis of the U.S. IVF market from 2019 to 2027 is provided to determine the market potential.
IVF Market Report Highlights
| Aspects | Details |
 By End User |
|
 By Cycle Type |
|
 Key Market Players | CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC, HOUSTON FERTILITY CENTER, FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF, NEW HOPE FERTILITY CENTER, SERVY MASSEY FERTILITY INSTITUTE, CONCEPTIONS REPRODUCTIVE ASSOCIATES OF COLORADO, FERTILITY CENTER OF SAN ANTONI, REPRODUCTIVE MEDICINE ASSOCIATES, SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM), BOSTON IVF |
Analyst Review
IVF services market, the adoption of IVF procedure is expected to increase in the future due to rise in infertile population across U.S. The adoption of IVF procedure is expected to increase in the future, owing to rise in infertile population across U.S and surge in same sex marriages. In addition, increase in success rate of IVF, surge in disposable income, and rise in trend of delayed pregnancies are expected to drive the market growth in the future. However, complications associated with the use of IVF and increase in procedure cost is expected to hinder the market growth. In addition, rise in funding for R&D by governments and private companies, introduction of fertility programs, and implementation of favorable regulatory policies for the development of IVF products are projected to supplement the growth of the market in the future
The total market value of U.S IVF Services market is $4,905.46 million in 2019.
The forcast period for U.S IVF Services market is 2020 to 2027
The market value of U.S IVF Services market in 2020 is $3,502.03 million.
The base year is 2019 in U.S IVF Services market
Top companies such as, Boston IVF, Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in U.S.
Fertility clinics segment is the most influencing segment owing technologically advanced IVF treatments for patients having fertility problems. Availability of a wide range of fertility treatments under one roof, coupled with government reimbursements majorly drive the growth of fertility clinic end user segment of the U.S IVF services market
The major factor that fuels the growth of the U.S IVF Services market includes delayed pregnancies in Women, Rise in popularity of IVF in the U.S, growth in rate of infertility and technological advancements in IVF treatment. This leads to surge in demand for U.S IVF Services devices which contribute to the growth of the market.
The average cost of IVF treatments in the U.S. costs around $12,400.
In vitro fertilization (IVF) procedures are adopted as a preferable choice of fertility treatment that involves fertilization of an egg outside the human body.
IVF is done to help a woman become pregnant. It is used to treat many causes of infertility, including: Delayed pregnancies; aging of women population, which lowers conception rates; and introduction of new & advanced products of IVF treatments enhance the market growth.
Loading Table Of Content...
